Lim Kok Thay
Known title: DirectorCIK: 0001470308
Lim Kok Thay's purchase track record
Lim Kok Thay has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/12/2024 | CELU | $5.33M | +89.4% | +35.9% | +17.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CELU | ▼ Sell | Other | 652,981 | $1.4M | 1/24/2025 | View on chart |
| CELU | ▼ Sell | Other | 535,274 | $1.1M | 1/24/2025 | View on chart |
| CELU | ▲ Buy | Open Market | 21,410,983 | $5.3M | 1/12/2024 | View on chart |
| CELU | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 | View on chart |
| CELU | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Celularity Q1 2027 EPS Up, Announces Partner & Board Member
Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.
Celularity Q1 2027 EPS Up, Announces Partner & Board Member. Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.